Selective balloon-occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: Retrospective comparison with conventional super-selective TACE

被引:45
作者
Irie, Toshiyuki [1 ]
Kuramochi, Masashi [1 ]
Kamoshida, Toshiro [2 ]
Takahashi, Nobuyuki [3 ]
机构
[1] Hitachi Gen Hosp, Dept Radiol, 2-1-1 Jyonann, Hitachi, Ibaraki 3170077, Japan
[2] Hitachi Gen Hosp, Hepato Gastroenterol, Hitachi, Ibaraki 3170077, Japan
[3] Tsukuba Mem Hosp, Dept Radiol, Tsukuba, Ibaraki, Japan
关键词
balloon-occluded transarterial chemoembolization; hepatocellular carcinoma; transarterial chemoembolization; ARTERIAL EMBOLIZATION; ANTICANCER DRUG; LIPIODOL; MIRIPLATIN; CT;
D O I
10.1111/hepr.12564
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AimSelective balloon-occluded transarterial chemoembolization (B-TACE) enables strong TACE; infusion of more volume of lipiodol emulsion and forceful injection of embolization materials. The aim of this study is to analyze the efficacy of B-TACE for patients with one or two hepatocellular carcinoma (HCC) nodules compared with conventional super-selective TACE using a microcatheter (C-TACE). MethodsWe retrospectively selected patients without previous history of TACE, with one or two HCC nodules, with performance status 0/1, and with liver function of Child-Pugh score A/B. Between 2008 and 2010, a 3-Fr microballoon catheter was used for targeted TACE (B-TACE group). Between 2005 and 2008, a 2-Fr microcatheter was used (C-TACE group). Control rates of primary nodule, overall survival rates and tumor-free rates in the liver were calculated for each group using the Kaplan-Meier method. Univariate analysis was performed to compare between the groups using the log-rank test. Multivariate analysis was performed for analysis of prognostic factors using Cox's proportional hazard model. The factors were B-TACE versus C-TACE, Child-Pugh score A versus B, single nodule versus double, large nodule versus small , elder versus not, and prior radiofrequency ablation treatment versus not. ResultsControl rates of the primary nodule were improved by B-TACE. B-TACE was an independent factor to improve both control rates of the primary nodule and overall survival rates. Child-Pugh score A was an independent factor to increase overall survival rates. There was no statistically significant difference in overall survival or tumor-free survival rates between the groups. ConclusionB-TACE was an independent factor to improve overall survival rates on multivariate analysis, but there was no significant difference in overall survival rates between B-TACE and C-TACE groups on univariate analysis.
引用
收藏
页码:209 / 214
页数:6
相关论文
共 13 条
[1]   Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma [J].
Arai, Hirotaka ;
Abe, Takehiko ;
Takayama, Hisashi ;
Toyoda, Mitsuo ;
Ueno, Takashi ;
Kakizaki, Satoru ;
Sato, Ken .
HEPATOLOGY RESEARCH, 2015, 45 (06) :663-666
[2]   Simulation model based on non-Newtonian fluid mechanics applied to the evaluation of the embolic effect of emulsions of iodized oil and anticancer drug [J].
Demachi, H ;
Matsui, O ;
Abo, H ;
Tatsu, H .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2000, 23 (04) :285-290
[3]   Revealing hepatic metastases from colorectal cancer: Value of combined helical CT during arterial portography and CT hepatic arteriography with a unified CT and angiography system [J].
Inaba, Y ;
Arai, Y ;
Kanematsu, M ;
Takeuchi, Y ;
Matsueda, K ;
Yasui, K ;
Hoshi, H ;
Itai, Y .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 174 (04) :955-961
[4]   Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodule during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloon-occluded Arterial Stump Pressure [J].
Irie, Toshiyuki ;
Kuramochi, Masashi ;
Takahashi, Nobuyuki .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 36 (03) :706-713
[5]   Predictive Factor of Local Recurrence after Balloon-Occluded TACE with Miriplatin (MPT) in Hepatocellular Carcinoma [J].
Ishikawa, Toru ;
Abe, Satoshi ;
Inoue, Ryousuke ;
Sugano, Tomoyuki ;
Watanabe, Yuhsuke ;
Iwanaga, Akito ;
Seki, Keiichi ;
Honma, Terasu ;
Nemoto, Takeo ;
Takeda, Keiko ;
Yoshida, Toshiaki .
PLOS ONE, 2014, 9 (07)
[6]   Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma [J].
Iwazawa, Jin ;
Ohue, Shoichi ;
Hashimoto, Naoko ;
Muramoto, Osamu ;
Mitani, Takashi .
EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (12) :3985-3992
[7]  
Kishimoto S, 2000, BIOL PHARM BULL, V23, P637
[8]   SMALL HEPATOCELLULAR-CARCINOMA - TREATMENT WITH SUBSEGMENTAL TRANSCATHETER ARTERIAL EMBOLIZATION [J].
MATSUI, O ;
KADOYA, M ;
YOSHIKAWA, J ;
GABATA, T ;
ARAI, K ;
DEMACHI, H ;
MIYAYAMA, S ;
TAKASHIMA, T ;
UNOURA, M ;
KOGAYASHI, K .
RADIOLOGY, 1993, 188 (01) :79-83
[9]   Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma [J].
Miyayama, Shiro ;
Yamashiro, Masashi ;
Shibata, Yoshihiro ;
Hashimoto, Masahiro ;
Yoshida, Miki ;
Tsuji, Kazunobu ;
Toshima, Fumihito ;
Matsui, Osamu .
JAPANESE JOURNAL OF RADIOLOGY, 2012, 30 (03) :263-270
[10]   Usefulness of Cone-Beam Computed Tomography During Ultraselective Transcatheter Arterial Chemoembolization for Small Hepatocellular Carcinomas that Cannot be Demonstrated on Angiography [J].
Miyayama, Shiro ;
Yamashiro, Masashi ;
Okuda, Miho ;
Yoshie, Yuichi ;
Sugimori, Natsuki ;
Igarashi, Saya ;
Nakashima, Yoshiko ;
Matsui, Osamu .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2009, 32 (02) :255-264